News

Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer

40% of women who inherit a mutatation in their BRCA1 gene will develop ovarian cancer in their lifetime. Posted September 7, 2021

Researchers in gynecologic oncology have begun testing a promising surgery for premenopausal women at high genetic risk for ovarian cancer that avoids early menopause and may prevent these malignancies from developing.

Studies have shown that most ovarian cancers actually begin to grow from cancer cells that developed in the fallopian tubes. This trial is testing if removing the fallopian tubes before menopause prevents ovarian cancer.

All | 2021 | 2020 | 2019 | 2018

Managing Cancer Pain: Are Better Approaches on the Horizon?

Pain is a common and much-feared symptom among people being treated for cancer and long-term survivors. Cancer pain can be caused by the disease itself, its treatments, or a combination of the two. It may be short-lived or... Read More

POSTED: 01/23/2019
SOURCE: NCI Cancer Currents Blog

Sensory nerve fibers (red) sprouting into prostate tumor cells (green) that have metastasized to the bone. Credit: Patrick Mantyh, Ph.D., JD, University of Arizona

Hepatitis Goes Undiagnosed in Cancer Patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show that an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but... Read More

POSTED: 01/17/2019
SOURCE: SWOG News

Portrait of Scott Ramsey, M.D., Ph.D.

For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target

A new study has identified a potential biomarker of early-stage non–small cell lung cancer (NSCLC). The biomarker could help diagnose precancerous lung growths (called nodules or lesions) and early-stage lung cancers... Read More

POSTED: 01/03/2019
SOURCE: NCI Cancer Currents Blog

Imaging scans identified a lung nodule (panels A and B) which, over the course of 11 months progressed (panels C and D) and, following a biopsy, was confirmed as lung cancer.

Pages